Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...
May I have your attention, please? May I have your attention, please? Aside from being an Eminem lyric, it’s also a sincere request from pharma brands to healthcare professionals (HCPs). HCP marketing ...
GSK Pharma delivered a better-than-expected performance in Q3, largely driven by robust volume growth in the general medicine ...
Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...
India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the ...
Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS ...
1 小时on MSN
Enhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were launched, generating sales of Rs 1,097 crore. The cardiac, anti ...
OMD India will lead the strategic marketing and media efforts for the company's portfolio of OTC brands, including Lacto ...
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果